GELWEAVE LUPIAE
LIVE

Serial Number

79144332

Owner

VASCUTEK LIMITED

Attorney

Thomas W. Cole

Filing Date

Jan 17, 2014

Add to watchlist:

No watchlists yet
View on USPTO

GELWEAVE LUPIAE Trademark

Serial Number: 79144332 • Registration: 4838737

GELWEAVE LUPIAE is a trademark filed by VASCUTEK LIMITED on January 17, 2014. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

VASCUTEK LIMITED (31 trademarks)

Newmains Avenue
Inchinnan, Renfrewshire PA4 9RR , GB

Entity Type: 11

Trademark Details

Filing Date

January 17, 2014

Registration Date

October 27, 2015

Published for Opposition

August 11, 2015

Cancellation Date

January 18, 2024

Goods & Services

Surgical apparatus and instruments for treating cardiovascular disease; medical apparatus and instruments for treating cardiovascular disease; prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 3, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Aug 3, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 20, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 1, 2023 INTS
INVALIDATION PROCESSED
Mar 1, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 13, 2023 INTR
CANCELLED SECTION 71
May 13, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 27, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 8, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 28, 2016 FICS
FINAL DISPOSITION PROCESSED
Apr 28, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 27, 2015 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 18, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 2, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 2, 2015 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Aug 7, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 22, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 22, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 4, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2015 CRFA
ASSIGNED TO LIE
Jun 25, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2015 GNRN
NON-FINAL ACTION E-MAILED
May 5, 2015 GNRT
NON-FINAL ACTION WRITTEN
May 5, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 16, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 16, 2015 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 17, 2014 GNFN
FINAL REFUSAL E-MAILED
Oct 17, 2014 GNFR
FINAL REFUSAL WRITTEN
Oct 17, 2014 CNFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 29, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 29, 2014 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2014 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2014 TROA
REFUSAL PROCESSED BY IB
May 23, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2014 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 30, 2014 RFCR
NON-FINAL ACTION WRITTEN
Apr 29, 2014 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 1, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 27, 2014 REPR